Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019

Bibliographic Details
Main Authors: Chengshui Chen, Feng Qi, Keqing Shi, Yuping Li, Ji Li, Yongping Chen, Jingye Pan, Tieli Zhou, Xiangyang Lin, Jinsan Zhang, Yongde Luo, Xiaokun Li, Jinglin Xia
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.35
id doaj-a1cda4824aa548b0ae0bbc1ffc4022a2
record_format Article
spelling doaj-a1cda4824aa548b0ae0bbc1ffc4022a22020-11-25T03:18:10ZengWileyClinical and Translational Medicine2001-13262020-06-01102n/an/a10.1002/ctm2.35Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019Chengshui Chen0Feng Qi1Keqing Shi2Yuping Li3Ji Li4Yongping Chen5Jingye Pan6Tieli Zhou7Xiangyang Lin8Jinsan Zhang9Yongde Luo10Xiaokun Li11Jinglin Xia12COVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaLiver Cancer Institute, Zhongshan Hospital Fudan University Shanghai ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaCOVID‐19 Headquarters The First Affiliated Hospital of Wenzhou Medical University Wenzhou Chinahttps://doi.org/10.1002/ctm2.35
collection DOAJ
language English
format Article
sources DOAJ
author Chengshui Chen
Feng Qi
Keqing Shi
Yuping Li
Ji Li
Yongping Chen
Jingye Pan
Tieli Zhou
Xiangyang Lin
Jinsan Zhang
Yongde Luo
Xiaokun Li
Jinglin Xia
spellingShingle Chengshui Chen
Feng Qi
Keqing Shi
Yuping Li
Ji Li
Yongping Chen
Jingye Pan
Tieli Zhou
Xiangyang Lin
Jinsan Zhang
Yongde Luo
Xiaokun Li
Jinglin Xia
Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019
Clinical and Translational Medicine
author_facet Chengshui Chen
Feng Qi
Keqing Shi
Yuping Li
Ji Li
Yongping Chen
Jingye Pan
Tieli Zhou
Xiangyang Lin
Jinsan Zhang
Yongde Luo
Xiaokun Li
Jinglin Xia
author_sort Chengshui Chen
title Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019
title_short Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019
title_full Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019
title_fullStr Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019
title_full_unstemmed Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019
title_sort thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical coronavirus disease 2019
publisher Wiley
series Clinical and Translational Medicine
issn 2001-1326
publishDate 2020-06-01
url https://doi.org/10.1002/ctm2.35
work_keys_str_mv AT chengshuichen thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT fengqi thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT keqingshi thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT yupingli thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT jili thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT yongpingchen thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT jingyepan thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT tielizhou thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT xiangyanglin thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT jinsanzhang thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT yongdeluo thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT xiaokunli thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
AT jinglinxia thalidomidecombinedwithlowdoseshorttermglucocorticoidinthetreatmentofcriticalcoronavirusdisease2019
_version_ 1724628477262430208